There are now at least 5 studies, led by Dr. Daniel Furst (a professor of rheumatology at the University of California at Los Angeles), assessing the safety and efficacy of Gleevec as a treatment for scleroderma. This is of great significance to scleroderma patients who have lacked an effective treatment for the disease. There is currently no treatment for scleroderma at the cellular level. Patients are now treated to relieve symptoms and lessen discomfort -- so a treatment that would target the disease process would be a huge advancement.
- Guide to Scleroderma
- Scleroderma Screening Quiz
- Inflammation: The Battle Within
- Fast Facts About Scleroderma
- Scleroderma - Test Your Knowledge
Join the Discussion:
Photo by jhonnyt (stock.xchng)